Chris Wolfram

Chris joined Health Advances in 2021 and brings experience in in product strategy, financial analysis, market landscaping, and due diligence across the biopharma and bioprocessing sectors.

Prior to joining Health Advances, Chris earned an MBA in Life Sciences from Harvard Business School and an MS and BS in Materials Science & Engineering from the University of Maryland College Park.